A 5443 Da peptide with sequence homology to defensins was purified from purple pole beans (Phaseolus vulgaris cv. 'Extra-long Purple Pole bean'). This peptide was isolated by adsorption on an affinity chromatographic medium AffiGel Blue gel and ion-exchange chromatographic media SP-Sepharose (sulfopropyl-Sepharose) and Mono S and by gel filtration on Superdex peptide. The peptide inhibited mycelial growth in Mycosphaerella arachidicola, Helminthosporium maydis, Fusarium oxysporum, Verticillium dahliae, Rhizoctonia solani, Candida albicans and Setosphaeria turcica with an IC 50 of 0.8, 0.9, 2.3, 3.2, 4.3, 4.8 and 9.8 μM respectively. Its antifungal potency was higher than that of the plant defensin coccinin (IC 50 > 50 μM). It induced membrane permeabilization in C. albicans as evidenced by SYTOX Green uptake, but did not affect erythrocyte membrane permeability. It inhibited growth in M. arachidicola by inducing chitin accumulation at hyphal tips as was shown by Congo Red staining. The antifungal activity was pH stable and thermostable. The peptide inhibited the proliferation of hepatoma (HepG2), breast cancer (MCF7), colon cancer (HT29) and cervical cancer (SiHa) cells but not that of human embryonic liver (WRL68) cells. Its antiHepG2 activity (IC 50 = 4.1 + − 0.8 μM, n = 3) was higher than that of another plant defensin, gymnin (IC 50 > 50 μM). Its anti-MCF7 activity (IC 50 = 8.3 + − 0.3 μM, n = 3) was similar to that of other plant defensins. It reduced the activity of HIV-1 reverse transcriptase with an IC 50 of 0.5 + − 0.1 μM, n = 3, much more potently than other plant defensins (IC 50 > 40 μM). There is the possibility of using the purple pole bean defensin for producing antifungal drugs and/or transgenic plants with fungal resistance.
INTRODUCTION
Defensin is derived from the Latin word 'defendo', which means 'to repel'. In 1985, Ganz et al. [1] isolated a group of structurally similar antimicrobial peptides that they designated as defensins based on their role in host defence. Since then, defensins have been known as a family of antimicrobial peptides with a characteristic motif rich in β-sheet and a framework of six disulfide-linked cysteine residues. Defensins have been reported from humans [2] , insects [3, 4] , other animals [5] and plants [6] [7] [8] [9] . Plant defensins elicit an antifungal activity and are classified as one category of antifungal proteins [10] . In plant defensins, emphasis has been placed on their antifungal activity. In comparison, studies on the biological activities of plant defensins other than antibacterial and antifungal activities [11] are few in number. Several studies in our laboratory have revealed that defensins,
Abbreviations used:
CoV, coronavirus; DTT, dithiothreitol; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide; SARS, severe acute respiratory syndrome; SP-Sepharose, sulfopropyl-Sepharose. 1 To whom any correspondence should be addressed (email b021770@mailserv.cuhk.edu.hk).
like other antifungal proteins, possess antiproliferative, HIV-1 reverse transcriptase inhibitory and immunomodulatory [12] [13] [14] activities.
The species Phaseolus vulgaris consists of many morphologically dissimilar cultivars such as pinto bean [15] , red kidney bean [16] and French bean [12] . Since the same type of protein from different cultivars may have different biochemical characteristics and biological activities [15, 16] , we undertook the present study to isolate and characterize an antifungal peptide from the purple pole bean (P. vulgaris cv. 'Extra-long Purple Pole Bean') that has not been examined before. We studied its antiproliferative activity towards a number of tumour cell lines, its inhibitory activity on HIV-1 reverse transcriptase and its antifungal activity towards a number of fungal species, filamentous as well as nonfilamentous. It was found that this peptide, with an N-terminal sequence similar to defensins, had highly potent biological activities when compared with other antifungal proteins.
MATERIALS AND METHODS

Materials
Purple pole beans were purchased from Jiangsu Province, Mainland China. The seeds have been authenticated by Professor Shiuying Hu (Honorary Professor of Chinese Medicine, CUHK). Affi-Gel Blue gel was obtained from Bio-Rad. The Superdex 75 HR 10/30 column was from GE Healthcare. Chemicals for amino acid sequence analysis were purchased from Hewlett-Packard (Palo Alto, CA, U.S. A.) . All other chemicals used were of analytical reagent grade.
Purification
The beans (500 g) were soaked overnight in distilled water and then blended in a Waring blender. Tris/HCl buffer (pH 7.8 ) was added to the supernatant obtained after centrifuging (10 000 g and 30 min) the resulting slurry until a Tris concentration of 10 mM was attained. The supernatant was then separated by chromatography on a 5 cm × 20 cm affinity chromatography column of Affi-Gel Blue gel (Bio-Rad) in 10 mM Tris/HCl buffer (pH 7.8).
Unadsorbed proteins (fraction B1) were eluted with the same buffer, whereas adsorbed proteins (fraction B2) were eluted with 10 mM Tris/HCl buffer (pH 7.8) containing 1 M NaCl. After dialysis, fraction B2 was subjected to cation-exchange chromatography on a 2.5 cm × 20 cm column of SP-Sepharose (sulfopropyl-Sepharose; GE Healthcare) that had been equilibrated with and then eluted with 10 mM ammonium acetate buffer (pH 4.5). After unadsorbed proteins came off the column, the column was eluted with 10 mM ammonium acetate buffer (pH 4.5) containing 0.2, 0.4 and 1 M NaCl to yield fractions S1, S2 and S3. After dialysis, fraction S2 was further purified by FPLC on an anion-exchange Mono S (GE Healthcare) column in 10 mM ammonium acetate buffer (pH 4.5) . After elution of unadsorbed proteins, the column was eluted with two linear NaCl concentration gradients (0-0.6 and 0.6-1 M) in the starting buffer to yield two adsorbed fractions M2 and M3. Fraction M2 was subjected to final purification on a Superdex peptide gel-filtration column (GE Healthcare). The main peak constituted purified antifungal peptide.
Protein determination
Protein concentration was determined by the dye-binding method (Bio-Rad) using BSA as a standard.
Tricine-SDS/PAGE
Tricine-SDS/PAGE was conducted according to the method of Schagger and von Jagow [17] . After electrophoresis using 18% acrylamide gel, the gel was stained with Coomassie Brilliant Blue. The molecular mass of the isolated antifungal peptide was determined by comparison of its electrophoretic mobility with those of molecular mass marker proteins from GE Healthcare including horse myoglobin peptides of different molecular masses: 16949, 14404, 10700, 8159, 6214 and 2512 Da.
MS
MS analysis of the antifungal peptide was performed on a Finnigan LCQ-MS, an instrument that essentially consists of an atmospheric pressure electrospray positive-ion source attached to a triple-quadrupole mass analyser. The purified peptide (100 pmol) was dissolved in water/methanol (50:50, v/v) containing 1% (v/v) acetic acid at a protein concentration of 5 μmol/l and then applied on the MS instrument.
Amino acid sequence analysis
The N-terminal amino acid sequence of purple pole bean antifungal peptide was determined by means of automated Edman degradation using a Hewlett-Packard 1000A protein sequencer equipped with an HPLC system [18] .
Assay of antifungal activity
The assays of the isolated antifungal peptide for antifungal activity towards the phytopathogenic fungi Mycosphaerella arachidicola, Fusarium oxysporum, Helminthosporium maydis, Rhizoctonia solani, Setosphaeria turcica, Verticillium dahliae, Valsa mali, Bipolaris maydis, Pythium aphanidermatum and Candida albicans, which are plant pathogens, were carried out in 90 mm × 15 mm Petri plates containing 10 ml of potato dextrose agar. After the mycelial colony had formed, sterile blank paper discs (0.625 cm in diameter) were introduced at a distance of 0.5 cm away from the rim of the mycelial colony. An aliquot of a solution of the isolated antifungal peptide was added to a disc. The plates were incubated at 25
• C for 72 h until mycelial growth had enveloped discs containing the control and had formed crescents of inhibition around discs containing samples with antifungal activity [19] .
To determine the IC 50 value for the antifungal activity of the isolated antifungal peptide, four doses of the peptide were added separately to four aliquots each containing 4 ml of potato dextrose agar at 45
• C, mixed rapidly and poured into four separate small Petri dishes. After the agar had cooled down, a small amount of mycelia, the same amount to each plate, was added. Only buffer without antifungal peptide served as a control. After incubation at 23
• C for 72 h, the area of the mycelial colony was measured and the inhibition of fungal growth was determined: To investigate the thermal (0-100 • C) stability and pH (0-14) stability, the isolated antifungal peptide was pretreated accordingly, and the antifungal activity assay was then conducted as mentioned above.
Assay of permeabilization of hyphal membrane
This assay was performed by observing the uptake of SYTOX Green, a high-affinity nuclear stain that penetrates cells with compromised membranes as described by Thevissen et al. [11] . Briefly, yeast (C. albicans) cultures were grown in the presence or in the absence of antifungal peptide. SYTOX Green (Invitrogen) was added to the yeast cultures (various final concentrations up to 0.5 μM). After incubation for 10 min, yeast cells were observed under a fluorescence microscope (Nikon TE2000).
Assay of chitin deposition at hyphal tips
This assay was conducted as described by Moreno et al. [21] to observe chitin deposition at hyphal tips of M. arachidicola. Pre-germination and incubation of fungal cultures with purple pole bean defensin were performed in 96-well microplates. After incubation with purple pole bean defensin, Congo Red was added until a final concentration of 1 mM was reached. Fluorescence was examined 10 min later by confocal microscopy using an excitation wavelength of 543 nm and an emission wavelength of 560-635 nm. The tips of growing hyphae were not stained with Congo Red, while hyphal tips with inhibited growth were stained.
Assay of haemolytic activity
This assay aimed to test whether the isolated antifungal protein affected erythrocyte membrane permeability. Rabbit erythrocytes were used in this assay. A 0.2 ml aliquot of antifungal peptide (various concentration up to 100 μM) in 10 mM PBS (pH 7.5) was mixed with rabbit erythrocytes (0.2 ml; 4%, v/v) and then incubated at room temperature (25
• C) for 1 h before centrifugation at 1000 g for 5 min. The amount of Hb released from disrupted erythrocytes was determined spectrophotometrically; 100% haemolysis was defined as attenuance at 540 nm (D 540 ) of Hb released from erythrocytes treated with 0.1% Triton X-100.
Assay of antiproliferative activity on tumour cell lines
The isolated peptide was assayed for its antiproliferative effect on tumour cell lines in view of previous reports that antifungal proteins may demonstrate this activity [12] . Various cell lines including hepatoma (HepG2), breast cancer (MCF7), colon cancer (HT29), cervical cancer (SiHa) and human embryonic liver (WRL68) cells were suspended in RPMI 1640 medium and adjusted to a cell density of 2 × 10 4 cells/ml. A 100 μl aliquot of this cell suspension was seeded in a well of a 96-well plate, followed by incubation for 24 h. Different amounts of the isolated peptide in 100 μl of complete RPMI 1640 medium were then added to the wells and incubated for 72 h. After 72 h, 20 μl of 5 mg/ml MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] in PBS was spiked into each well and the plates were incubated for 4 h. The plates were then centrifuged at 325 g for 5 min. The supernatant was carefully removed and 150 μl of DMSO was added to each well in order to dissolve the MTT-formazan at the bottom of the wells. After 10 min, the attenuance at 590 nm was read by using a microplate reader.
Assay for HIV reverse transcriptase inhibitory activity
The isolated peptide was assayed for HIV reverse transcriptase inhibitory effect in view of previous reports that antifungal proteins may demonstrate this activity [12] . The assay was carried out according to instructions supplied with the assay kit from Boehringer Mannheim. The assay takes advantage of the ability of reverse transcriptase to synthesize DNA, starting from the template/primer hybrid poly (A) oligo (dT) 15 . The digoxigenin-and biotin-labelled nucleotides at an optimized ratio are incorporated into one of the same DNA molecules, which are freshly synthesized by the reverse transcriptase. The detection and quantification of synthesized DNA as a parameter for reverse transcriptase activity follows a sandwich ELISA protocol. Biotin-labelled DNA binds to the surface of microtitre plate modules that have been precoated with streptavidin. In the next step, an antibody directed to digoxigenin, conjugated to peroxidase, binds to the digoxigenin-labelled DNA. In the final step, the peroxidase substrate is added. The peroxidase enzyme catalyses the cleavage of the substrate, producing a coloured reaction product. The attenuance of the sample at 405 nm can be determined using a microtitre plate (ELISA) reader and is directly correlated to the level of reverse transcriptase activity. A fixed amount (4-6 ng) of recombinant HIV-1 reverse transcriptase was used. The inhibitory activity of the antifungal peptide was calculated as percentage inhibition as compared with a control without the antifungal peptide [12] .
Assays for HIV-1 integrase inhibitory activity and SARS (severe acute respiratory syndrome) CoV (coronavirus) proteinase inhibitory activities
The two assays were carried out as described in [12] .
Assay of the ability to inhibit HIV-1 integrase: expression and purification of recombinant HiV-1 integrase
The plasmid that expressed His-tagged wild-type HIV-1 integrase, pT7-7-His (Y|TX)-HIV-1-IN, was a gift from Professor S. A. Chow (School of Medicine, UCLA, Los Angeles, CA, U.S. A.) . To express the protein, a 1 litre culture of Escherichia coli BL21 (DE3) cells containing the expression plasmid was grown at 37
• C until the D 600 reached 0.7-0.8. Cells were induced by the addition of 0.8 mM IPTG (isopropyl β-D-thiogalactoside) and harvested, after 4 h of incubation, by centrifugation at 6000 g for 10 min at 4
• C. Cells were suspended at a concentration of 10 ml/g wet cell paste in 20 mM Tris/HCl buffer (pH 8.0) containing 0.1 mM EDTA, 2 mM 2-mercaptoethanol, 0.5 M NaCl and 5 mM imidazole. Lysozyme was added to a concentration of 0.2 mg/ml. After incubation at 4
• C for 1 h, the lysate was sonicated and centrifuged at 40 000 g for 20 min at 4
• C. The pellet was homogenized in 50 ml of buffer A (20 mM Tris/HCl, pH 8.0, 2 M NaCl and 2 mM 2-mercaptoethanol) containing 5 mM imidazole. The suspension was rotated at 4
• C for 1 h and cleared by centrifugation at 40 000 g for 20 min at 4
• C. The supernatant was loaded on to a 1 ml chelating Sepharose (GE Healthcare) column charged with 50 mM imidazole. The column was washed with 5 column volumes of buffer A containing 5 mM imidazole, and the protein was eluted with 3 column volumes of buffer A containing 200 and 400 mM imidazole respectively. Protein-containing fractions were pooled, and EDTA was added to a final concentration of 5 mM. The protein was dialysed against buffer B (20 mM Hepes, pH 7.5, 1 mM EDTA, 1 M NaCl and 20% glycerol) containing 2 mM 2-mercaptoethanol, and then against buffer B containing 1 mM DTT (dithiothreitol). Aliquots of the protein were stored at -70
• C.
HIV-1 integrase assay
A non-radioactive ELISA-based HIV-1 integrase assay was performed according to the DNA-coated plate method. In this study, 1 μg of SmaI-linearized pBluescript SK was coated on to each well in the presence of 2 M NaCl as target DNA. The donor DNA was prepared by annealing VU5BR (5 -biotin-GTGTGGAAAA-TCTCTAGCAGT-3 ) and VU5 (5 -ACTGCTAGAGATTTTCC-ACAC-3 ) in 10 mM Tris/HC1 (pH 8.0), 1 mM EDTA and 0.1 M NaCl at 80
• C followed by 30 min at room temperature. Integrase reaction was performed in 20 mM Hepes (pH 7.5) containing 10 mM MnCl 2 , 30 mM NaCl, 10 mM DTT and 0.05% Nonidet P40 (Sigma). After the integrase reaction, the biotinylated DNA immobilized on the wells was detected by incubation with streptavidin-conjugated alkaline phosphatase (Boehringer Mannheim), followed by colorimetric detection with 1 mg/ml PNPP (p-nitrophenyl phosphate) in 10% diethanolamine buffer (pH 9.8) containing 0.5 mM MgCl 2 . The attenuance due to the alkaline phosphatase reaction was measured at 415 nm. The ribosome inactivating protein trichosanthin was used as a positive control.
Screening for inhibitory effect on SARS CoV protease
The activity of SARS CoV protease was indicated by a cleavage of designed substrate, which was composed of two proteins linked by a cleavage site for SARS CoV protease. The reaction was performed in a mixture containing 5 μM SARS CoV protease, 5 μM sample and 20 μM substrate and buffer (20 mM Tris/HCl, pH 7.5, 20 mM NaCl and 10 mM 2-mercaptoethanol) for 40 min at 37
• C. After 40 min, the reaction was stopped by heating at 100
• C for 2 min. Then the reaction mixture was analysed by SDS/PAGE. If SARS CoV protease is inhibited by the test sample, there is only one band, which is the intact substrate, shown in SDS/PAGE [12] .
RESULTS
Affinity chromatography of the extract of purple pole bean on Affi-Gel Blue gel yielded a larger unadsorbed fraction, B1, devoid of antifungal activity and a smaller but sharper fraction, B2, in which antifungal activity was concentrated ( Figure 1A) . Cationexchange chromatography of fraction B2 on SP-Sepharose gave rise to three fractions of similar size, S1, S2 and S3 ( Figure 1B) . Antifungal activity was confined to fraction 2 eluted with 0.4 M NaCl in 10 mM ammonium acetate buffer (pH 4.5). FPLC of fraction S2 on Mono S resulted in a small unadsorbed fraction, M1, without antifungal activity. Elution of the adsorbed proteins with the first NaCl concentration gradient (0-0.6 M) produced two fractions: M2 and M3. Application of the second 0.6-1 M NaCl gradient and then of 1 M NaCl did not elute any more proteins ( Figure 1C ). Antifungal activity was restricted to fraction M2. Fraction M2 was subsequently resolved on Superdex peptide into a main fraction, P1, with antifungal activity and a tiny fraction, P2, without activity ( Figure 1D) . Fraction P1 displayed a single band with a molecular mass of 5.5 kDa in Tricine-SDS/PAGE ( Figure 2A ) and a 5443 Da peak in MS ( Figure 2B ). The yields of the various active chromatographic fractions are recorded in Table 1 . The purified antifungal peptide exhibited an N-terminal sequence with similarity in general to those of defensins. There was remarkable sequence resemblance among defensins from different cultivars of P. vulgaris including purple pole bean, haircot bean and white cloud bean. Defensins of different Phaseolus species are also structurally very much alike. However, there may be sequence differences between purple pole bean defensin and non-Phaseolus defensins ( Table 2) . The defensin inhibited mycelial growth in a number of fungal species tested including
M. arachidicola, H. maydis, F. oxysporum, V. dahliae, R. solani, C. albicans and S. turcica (Figure 3). No inhibitory activity was demonstrated towards V. mali, B. maydis and P. aphanidermatum.
The IC 50 values of its antifungal activity towards the aforementioned fungal species were 0.8, 0.9, 2.3, 3.2, 4.3, 4.8 and 9.8 μM respectively. In the assay of SYTOX Green uptake, 5 μM of purple pole bean defensin could induce membrane permeabilization in C. albicans as evidenced by increased dye uptake when viewed under a fluorescence microscope (results not shown). The percentage of C. albicans cells that took up SYTOX Green and were stained green increased as the concentration of purple pole bean defensin, increased (20, 60 and 75% at 2.5, 5 and 10 μM respectively). However, it failed to induce membrane permeabilization in rabbit erythrocytes (detailed results not shown). The hyphal tips of M. arachidicola were stained by Congo Red after treatment with 5 μM purple pole bean defensin, indicating inhibition of growth (results not shown). The antifungal activity of the defensin was stable throughout the temperature range 0-100
• C and the pH range 0-14 (results not shown).
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Figure 1 Purification of purple pole bean defensin by chromatography on (A) Affi-Gel Blue gel, (B) SP-Sepharose, (C) Mono S and (D) Superdex peptide
Arrows indicate elution with NaCl in starting buffer. Antifungal activity was confined to fractions B2, S2, M2 and P1 respectively.
Figure 2 (A) Tricine-SDS/PAGE of purple pole bean defensin and (B) MS analysis of purple pole bean antifungal defensin
The defensin exerted an antiproliferative action on a variety of tumour cells comprising HepG2, MCF7, SiHa and HT29 cells, but there was no similar effect on embryonic liver WRL68 
DISCUSSION
The antifungal peptide isolated in the present study is a defensin.
It possesses an N-terminal sequence bearing considerable structural resemblance to plant defensins, especially those of Phaseolus species. Its molecular mass is within the range reported for defensins. Its chromatographic behaviour on Affi-Gel Blue gel and cation exchange resins is similar to what has previously been reported for defensins, defensin-like peptides [13, 14] and other antifungal proteins and peptides [16,20, Purple pole bean defensin suppresses mycelial growth in a large variety of filamentous fungal phytopathogens, some of which (such as H. maydis, S. turcica and V. dahliae) have so far not been shown to be susceptible to leguminous defensins/defensinlike peptides [12] [13] [14] . It also exerts inhibitory activity on C. albicans, a non-filamentous fungus that is a human pathogen. Thus purple pole bean defensin is a broad-spectrum antifungal agent and could be employed in the production of a transgenic crop with an aim to confer augmented resistance on fungal pathogens. The fungi responsive to the action of purple pole bean defensin, include the following pathogenic fungi: M. arachidicola, F. oxysporum, H. maydis, R. solani, S. turcica and V. dahliae. However, the fungal species V. mali, B. maydis and P. aphanidermatum are not susceptible to the isolated purple pole bean defensin, indicating some specificity of antifungal action. Its antifungal potency against R. solani, M. arachidicola and F. oxysporum is similar to most other plant defensins but higher than that of coccinin [27] . The antifungal activity of the isolated peptide is pH stable and thermostable, similar to previously isolated defensins [13] .
In the SYTOX Green uptake assay, it is found that purple pole bean defensin induces membrane permeabilization in C. albicans, because it increases staining of the yeast cells with SYTOX Green. SYTOX Green is a high-affinity nucleic acid stain that fluoresces on nucleic acid binding. It can only penetrate cells with compromised plasma membranes [7, 19] . Previously, defensins were reported to induce membrane permeabilization in many different fungal species [11] . A basic, low-molecular-mass antifungal protein from Aspergillus giganteus was also reported to induce membrane permeabilization of fungal cells [21] . The antifungal activity of purple pole bean defensin may be attributed to an alteration of fungal membrane permeability, but the defensin does not disrupt the membranes of erythrocytes. This implies that there is selectivity of the defensin in inducing membrane permeabilization. SYTOX Green staining has been employed in the study of the membrane permeabilizing action of only some antifungal proteins, including wheat non-specific lipid transfer proteins [28] , potato aspartic proteases [29] , chilli pepper antifungal peptides [30] , A. giganteus antifungal protein [21, 31, 32] , antifungal protein from the marine bacterium Streptomyces sp. strain A p77 [33] , scorpion antifungal protein opistoporins 1 and 2 [34] and antifungal peptide from Bothrops jajaraca venom [35] . Only three non-defensin plant antifungal proteins [28] [29] [30] have been studied using SYTOX Green staining. The previous use of SYTOX Green staining in the membrane permeabilizing action of plant defensins is limited to the study of Raphanus satious defensin on the fungus Neurospora crassa [36, 37] and the study of Dahlia merckii defensin on the yeast Saccharomyces cerevisiae [36] .
Congo Red has a strong affinity for chitin in the fungal cell wall. Actively growing hyphae do not have much chitin deposit at the tips and show little Congo Red staining. Staining is intense in hyphae with impeded growth [21] . In the Congo Red staining assay, the tips of M. arachidicola hyphae exposed to purple pole bean defensin were stained intensely with the dye, indicating deposition of chitin and consequent retardation of hyphal growth. This observation is similar to the findings of Moreno et al. [21] showing that the hyphal tips of the rice blast fungus Magnaporthe grisea were stained by Congo Red after treatment with A. giganteus antifungal protein. Congo Red staining has been used in the study of the mode of action of antiscrapie drugs [38] and systemic amyloidosis in human tissues [39, 40] and susceptibility of Candida spp. from intensive care unit patients to the antifungal drugs amphoterium B, fluconazole and flucytosine [41] . However, very few antifungal proteins, including maize ribosome inactivating protein and A. giganteus antifungal protein, have been shown to inhibit the development of Aspergillus spp. and the rice blast fungus Ma. grisea respectively, as demonstrated by Congo Red staining [21, 42] .
The defensin from purple pole bean is endowed with a highly potent antiproliferative activity towards tumour cells, especially hepatoma (HepG2) cells, breast cancer (MCF7) cells and cervical (SiHa) cells. Its different inhibitory potencies towards different tumour cells are in keeping with similar observations on other antitumour proteins such as ribosome-inactivating proteins [43] , which represent another class of antifungal proteins [10] . Previously, leguminous defensins/defensin-like peptides were demonstrated to inhibit HL60, L1210, HepG2 and MCF7 tumour cells [13] . The present findings add cervical cancer (SiHa) cells to the list of tumour cells susceptible to defensin-like peptides. The antiproliferative activity of purple pole bean defensin (IC 50 = 4.1 + − 0.8 μM, n = 3) against HepG2 cells is much more potent than that of the defensin, gymnin (IC 50 > 50 μM) [13] . The antiproliferative activity of purple pole bean defensin (IC 50 = 8.3 + − 0.3 μM, n = 3) against MCF7 cells is somewhat less potent than that of the defensin sesquin (IC 50 = 6 μM) [44] and cloud bean defensin (IC 50 = 6 μM) [45] .
Purple pole defensin displays a highly potent inhibitory activity against HIV-1 reverse transcriptase, with an IC 50 below 1 μM. Its potency is higher than those of plant defensins [12] [13] [14] and many other anti-HIV-1 natural products [46] . The mechanism of inhibition is likely to be protein-protein inhibition, as in the case of inhibition of HIV-1 reverse transcriptase by the homologous protease. However, unlike some other antifungal proteins [47] , it is devoid of inhibitory activity towards HIV-1 integrase. It resembles French bean defensin-like peptide in its lack of inhibitory activity toward HIV-1 integrase and SARS CoV proteinase [12] . The HIV-1 reverse transcriptase inhibitory potency of purple pole bean defensin (IC 50 = 0.5 + − 0.1 μM, n = 3) is much higher than those of other defensins including sesquin (IC 50 = 100 μM) [43] , limenin (IC 50 = 106 μM) [48] , cloud bean defensin (IC 50 = 120 μM) [45] , coccinin (IC 50 = 41 μM) [27] and spotted bean (not active) [49] .
In the present study, a defensin was purified by using only an affinity column, two cation-exchange columns and a gel filtration column. This defensin demonstrates potent, broad-spectrum antifungal activity towards M. arachidicola, F. oxysporum, H. maydis, R. solani, S. turcica and V. dahliae. It is approx. 5.4 kDa in molecular mass and has an N-terminal sequence characteristic of defensins, suggesting that it is a typical plant defensin.
Currently, azoles, polyenes and fluorinated pyrimidines [11, 50] are the available antifungal drugs. However, because of
the presence of fungal strains with multidrug resistance, there is a need to search for new drugs. In the future, plant defensins such as purple pole bean defensin may be developed into antimicrobial drugs for use in humans. On the other hand, these defensins may also be used for biological control of crop pathogens. Transgenic plants harbouring the genes of plant defensins such as purple pole bean defensin may be robust and resistant to pathogenic fungi.
In summary, the thermostable and pH stable defensin isolated from purple pole bean in the present study exhibited more potent antifungal, antiproliferative and HIV-1 reverse transcriptase inhibitory activities than some of the previously reported defensins/defensin-like peptides. An additional number of fungal species (i.e. H. maydis, R. solani, S. turcica, V. dahliae and C. albicans) and tumour cell lines (i.e. SiHa) have been shown to be susceptible to a defensin-like peptide in the present study. Its antifungal activity could be attributed to a permeabilizing effect on the fungal membrane and to induction of chitin deposition at the hyphal tip, thus restricting hyphal growth. In addition to antifungal proteins [13, 14, 16, 20, [22] [23] [24] [25] , it is now known that lectins [12] , ribosome-inactivating proteins [43] , protease inhibitors [25] and RNases [22] may also have some or all of the following activities: antifungal, anti-HIV-enzyme and antiproliferative activities. Thus all of these proteins are considered to be defence proteins that protect against invasion of harmful foreign organisms.
